When MMP-9 protein and mRNA levels were combined, they had 87% sensitivity and 71% specificity for identifying patients with cognitive improvement 4 weeks after stroke (Włodarczyk et al., 2023). The gene discussed is MMP9; the disease is stroke disorder.